Supreme Cannabis Revenue Soars 382% to $10M Amid Ongoing Expansion


Ryan Allway

May 23rd, 2019

App, Exclusive, News, Top News


The Supreme Cannabis Co. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) reported fiscal third quarter revenue that soared 382% year-over-year and 29% sequentially to $10 million. The gains were largely due to a 63% increase in recreational cannabis sales.

“Revenue growth was driven by an increase in our capacity at the 7ACRES facility, a ramping up of our product packaging capabilities and, we believe, consumer preference for high-quality cannabis,” says CEO Navdeep Dhaliwal.

While many licensed producers have focused on expanding production capacity, the company’s consumer-oriented approach has led to strong consumer feedback, status as a top-ten revenue producer in the industry, and recognition as a coast-to-coast award-winning premium brand. The company’s leading position as a premium brand could insulate it from the effects of commoditization and maintain premium margins over time.

The company began selling products into the recreational market with its award-winning “Respect the Plant” marketing campaign. Sales revenue from recreational markets were a key revenue driver during the quarter with a 63% sequential increase. In addition, the company continues to provide high-end dried flower to wholesale buyers, including Tilray Canada Inc. (NASDAQ: TLRY), under the original terms of those agreements.

Growing Revenue & Profitability

Supreme Cannabis plans to further expand its revenue and profits by increasing production capacity and moving into new higher-margin markets.

7ACRES recently received Health Canada approval for an additional 50,000 sq. ft. of production space, which brings its total licensed production space ot 230,000 sq. ft. Along with new technologies and the licensing of all 25 flowering rooms, management projects that its production capacity could reach approximately 50,000 kilograms per year.

At the same time, the company has been working with MediPharm Labs Inc. (TSX-V: LABS) to produce premium oil products. The two companies are operating under a three-year agreement whereby 7ACRES will supply a minimum of 1,000 kilograms of high-quality cannabis trim as input for extraction and production of premium oil products. These high-margin products will be sold under the Supreme Cannabis brand.

The company also agreed to acquire BlissCo, a distinct and authentic premium wellness brand, following its strategic partnership and prior investment. The transaction enables BlissCo to focus its business around the production and commercialization of cannabis oils and topicals for the premium wellness consumer and opens the door to a new revenue stream and market opportunity for Supreme shareholders.

Investing in the Future

Supreme Cannabis also continues to invest in research and development initiatives aimed at improving its products.

For example, the company recently launched a cannabis genetics company, Cambium Plant Sciences, that will focus on developing next generation premium cannabis genetics for recreational, medical and wellness applications. The subsidiary will operate out of a 34,000 sq. ft. facility in Goderich, Ontario and has already commenced the Health Canada licensing process that’s required prior to entering operation.

Its Medigrow investment, located in Lesotho, also continues to make progress in building future international expansion opportunities. The company scaled its operations to more than 250 employees and successfully achieved a positive Certificate of Analysis from a U.S.-based laboratory. Supreme Cannabis believes that the company could reach an annual run rate of 40,000 liters of cannabis extract with additional scaling efforts.

Looking Ahead

The Supreme Cannabis Co. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) has made significant progress in growing its revenue during the fiscal third quarter. In addition, the company continues to advance its efforts to grow revenue, increase profitability, and expand its operations into international markets through various initiatives.

Investors may want to keep an eye on these efforts over the coming quarters.

For more information, visit the company’s website at www.supreme.ca.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading